Roche reports additional safety data of satralizumab in NMOSD
NMOSD is a rare, debilitating autoimmune disease of the central nervous system. Credit:
Birth Into Being.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more